Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications
In this study, we proposed a systems biology approach to investigate the pathogenic mechanism for identifying significant biomarkers as drug targets and a systematic drug discovery strategy to design a potential multiple-molecule targeting drug for type 2 diabetes (T2D) treatment. We first integrate...
Main Authors: | Shen Chang, Jian-You Chen, Yung-Jen Chuang, Bor-Sen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/1/166 |
Similar Items
-
Investigating Core Signaling Pathways of Hepatitis B Virus Pathogenesis for Biomarkers Identification and Drug Discovery via Systems Biology and Deep Learning Method
by: Shen Chang, et al.
Published: (2020-08-01) -
Investigating Common Pathogenic Mechanisms between <i>Homo sapiens</i> and Different Strains of <i>Candida albicans</i> for Drug Design: Systems Biology Approach via Two-Sided NGS Data Identification
by: Shan-Ju Yeh, et al.
Published: (2019-02-01) -
A Novel Antimicrobial Drug Discovery Approach for the Periodontal Pathogen Porphyromonas gingivalis
by: Stone, Victoria N
Published: (2015) -
Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery
by: Martina Maccesi, et al.
Published: (2019-10-01) -
Carrier-Mediated Drug Uptake in Fungal Pathogens
by: Mónica Galocha, et al.
Published: (2020-11-01)